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m7852 Estrogen Decreaaes the Level of Circulating Cellular
Adhesion Molecules in COrOnaf’yArtery Disease
T. Caulin-Glaser, J. Brennan, K. Bunger, M. Remetz, W. Farrell, S. Pfau,
J.F. Setaro, J.R. Bender, M. Cleman, H. Cabin. Ya/eUniversity Scfroo/of
Medicine,New Haven, CT USA
Endothelial cell activation results in expression of adhesion molecules, aug-
menting leukocyte adhesion, recruitment and subsequent development of
atherosclerosis. The incidenceof CAD is less in women than men and
this is in part due to the cardioprotective effect of estrogen (E2). We have
previously demonstrated in-vitro that EZpretreatment of endothelial cells re-
sults in down-regulation of adhesion molecule gene expression. In this study
we evaluate the effect of chronic estrogen replacement (ERT) on serum
levels of soluble adhesion molecules in patients with CAD. We studied:
premenopausal women; normal men; postmenopausal women (+) CAD, (+)
ERT; postmenopausal women (+) CAD, (-) ERT; man (+) CAD. Serum EZ
(measured by RIA) and circulating vascular adhesion molecule (sVCAM-I
measured by ELISA) levels wera examined.
Results:
PremenO- Normal Postmeno Postmeno Males
pausal males (+) ERT (-) ERT (CAD)
Number 10 10 6 11
Estradiol(pmolll) 380 300 :: 24
(i SDrange) (26G500) :$-35) (180-420) (lo-so) (14-34)
(sVCAM-1(nglml) 475
(*SD range) (34+09) :5?$-680) !::He6) f:’%j:O) /%256)
P <0.05 P <0.05
Cone/usion:Statistically $i9nificant increases insVCAM-1 Ievelsarefound
in all patients with significant CAD. Postmenopausal women with CAD not
receiving ERT have higher levels of sVCAM-I compared with women on ERT.
Both groups of postmenopausal women with CAD have elevated sVCAM-
1 levels compared with premenopausal women. EZ likely exerts pert of its
protective effects by decreasing expression of adhesion molecules.
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El7853 Contribution of Nitric Oxide to CoronaryVasodilation by Eetrogen in Postmenopausal
Wornen
V. Guetfa, A.A. Quyyumi, A. Prasad, J.A. Panza, R.O. Cannon, Ill. fW-fLB/,
N/H, Bethesda, MD, USA
At physiological concentrations, 17&estradiol (EzJenhancee endothelium-
dependent coronaw vascdilation in postmenopausal women, but by an un-
known mechaniem. To assess the contribution of nitric oxid6 (NO) to the
vascular effects of Ez, we measured coronary epicardial and microvaecular
responses to the peak vasodilating dose of intracoronafy (i.e.) acefylcholina
(ACH:8-300 wglmin x 2 rein), before and after i.e. E2 (75 n!Ymin x 15
rein) in 17 eetrogen-deficient women. This testing was repeated following
inhibition of NO synthesis with i.e. NG-monomethyl-L-arginine(L-NMMA: 64
~mo!lmin x 5 rein). Coronary flow (CF) was derived from i.e. Doppler,flow
velocity and epicardial diameter (D) distal to the flow-wire. Results: E2 po-
tentiated peak ACH-stimulated CF (+40 + 52 to +138 + 116%; mean +
SD), converted epicardial constriction (–13 * 9%) to dilation (+3 + 12%),
and potentiated microvascular dilatation (coronaw resistance –24 + 25 to
-51 + 20%) compared with respective pre-ACH baseline values in 10 of
the 17 women (all changes in ACH responses p <0.01 by selection) at
coronary einus EZ = 484 + 198 pg/mL. However, during L-NMMA infusion,
E2-potentiation of ACH effects were blocked in these 10 women (CF +54 &
53 to +58 +63%, epicardial D –8 + 9 to –8 * 9%, coronaty resistance –28
+28 to –27 + 27% compared with respective pre-ACH baeeline values: all
changes in ACH responses p ?0.67). In the remaining 7 women who did
not raspond to Ez, L-NMMA did not alter the vascular responeeto reinfusion
of Ez. Thue, Ez’s effects on endothelium-dependent coronary epicardial and
microvascular vasodilation at physiological concentrations are mediated by
enhanced synthesis or bioactivity of NO.
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m7854 Arterial Reactivity is Enhancad in Genatic MalasTaking High Dose Estrogens
J.A. McCrohon, W.A.W. Walters, J.T.C. Robinson, R. McCradie, L. Turner,
M.R. Adams, D.J. Handelsman, D.S. Celerrnajer. Royal Prince Alfred
Hospital, Sydney Australia, John Hunter Hospital, Newcaatle, Austra/is
Eatrogens have been shown to enhance arierial reactivity in women and
thereby potentially confer cardiovascular benefit. The vascular effects of
long-term estrogen therapy in genetic males is unknown. We therefore stud-
ied arterial physiology in 30 genetic males; 15 male to female transsexuals
receiving long-term high dose estrogen therapy and 15 healthy male controls
matched for age, smoking history and vessel size. Using external vascular
ultrasound, brachial artery diameter was measured at rest, after flow in-
crease (causing endothelium-dependent dilatation, EDD) and after nitroglyc-
erin (GTN, an endothelium-independent dilator). Blocd pressure, cholesterol
and testosterone levels were also measured in each subject.
Total and free testosterone index levels were significantly lower in the
transsexuals comparad to the controls (p < 0.001). In contrast, EDD was
significantly higher in the transsexuals (7.1 + 3.1 VS3.2A 2.8%, p = 0.001),
as was the GTN response (21.2 + 6.7 vs 14.6 & 3.3Y0,p = 0.002). Total
and HDL cholesterol, blcmdpressure levels and baseline vessel size were
aimilar in the two groups. On multivariate analyais, enhanced EDD wae
associated with estrogen therapy (partial r-value = 0.42, p = 0.02) and with
low total cholesterol level (p = 0.04). An enhanced GTN response was also
significantly associated with estrogen therapy (p= 0.03).
Long-term treatment with high dose estrogens is therefore associated
with enhanced vascular reactivity in genetic males. This may be due to the
effects of estrogen excess and/or due to androgen suppression.
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R GenderD,fferen.e ln,mProvementof
Endothelium-Dependent Vasodilation After
Supplementation of Estrogen
H. Kawano, T. Motoyama, O. Hirashima, M. Ohgushi, K. Kugiyama,
H. Ogawa,H.Yasue.Kumamoto Unlverai~, Kumamoto, Japan
Estrogentherapy has been shown to reduce the risk of cardiovascular events
in postmenopausal women, snd the augmented release of endothelium-
derlved nitric oxide (NO) by estrogens has been suggested to be one of
the mechanisms for the oardioproteorive effects of estrooen. We examined
whether estrogen supplementation improves endothelium~dependentvaeodi-
Iation in heelthy man and healthy postmenopausal women, and if there is,
whether thera is a gender difference in the improvement of andothelium-
dependent vaeodilation. With high-resolution ultrasound, we measured di-
ameterand blood flow of brachial artery at rest, during reactive hyparemla
following transient occlusion for 4.5 minutes (which causea endothelium-
dependent vasodilation), and after sublingual nitroglycerin administration
(0.3 mg) (endothelium-independent dilation) before and after supplemen-
tation of 17-beta estrediol (E2;1OOpg) transdennally for 38 hours in 15
postmenopausal women (mean 63 yeara) and in 15 age- and risk factors for
atherosclerosis matched men. E2 supplementation augmented the increases
in diameter during reactive hyperemia in women (6.1 + 0.6 vs 10.9 + 0.6Y0,
p < 0.01), but not in men (6.2 + 0.6 vs 6.4 + 0.7%, NS). There wee no
significant difference in the increases in blood flow during reactive hyperemia
and in diameter after nitroglycerin between before and after E2 supplemen-
tation in either women or men. The serum E2 level was increased after E2
aupplementation in both groups. .E2 supplementation increaae the aerum
level of nitrite/nitrate which was stable metabolizesof NO, meaaured by the
Griese reaction, in women (84.9+ 6.7 va 93.7 + 19.4 pmolfl, p < 0.05), but
not in men (58.8 + 16.7 vs 61.8 + 15.4 ,umol/1,NS). In conclusion, E2 sup-
plementation increases NO production/releaae, leading to improvement of
endothelium-dependent vasodilation in women, but not in men. Thue, these
may be gender differences in the effects of estrogen therapy on endothelial
functions and NO productionlreleaae.
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~{ Effe.tofTest.ostarocoronaY~,ood~“““-
Valocity to Acetylcholine in Men with Coronarv
Artery Dieease
C.M. Beale, G.M.C. Roeano, G. Sontag, P.Collins. National Heart& Lung
Institute, Imperial College Schoo/ofMedicine and Royal Brompton Hospital,
London, UK
Testosterone (T) is aasumed to be a risk factor for coronary artery disease
(CAD) since men have a greater incidence of CAD than women of a sim-
ilar age. However, the effect of testosterone on the coronary circulation is
unknown. To evaluate the effects of testosterone on the human coronary
circulation we studied the effect of intracoronary infusions of testosterone
(10-10-10-7 M) in 11 men with CAD (mean + SD; aged 63 + 10 years).
All patients underwent measurement of coronary blood flow velocity at rest,
after control infusion (ethanol), infusion of papaverine (8 mg), then acetyl-
choline (ACh) 10-7–10-5 M, using intracoronary doppler. Infusions of ACh
were performed before and immediately after infusions of T. Coronary flow
velocity was not significantly changed from baseline after ethanol control
(20 + 6 vs 19 + 7 cmk.ec, baseline vs ethanol, respectively, P= NS). ACh
significantly increased coronary flow velocity before and after administration
